Skip to content
← Full study record

NCT05185947 · MORE INFO

Limitations, agreements, and source contact

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis · Source last updated 2026-06-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
andrew.blakely@nih.gov
organization
National Cancer Institute
phone
240-760-7647
title
Dr. Andrew Blakely
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
email
andrew.blakely@nih.gov
organization
National Cancer Institute
phone
240-760-7647
title
Dr. Andrew Blakely

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice